HUP0301199A2 - Dioxo-tiazolidin-származék és antidiabetikumként történő alkalmazása - Google Patents

Dioxo-tiazolidin-származék és antidiabetikumként történő alkalmazása

Info

Publication number
HUP0301199A2
HUP0301199A2 HU0301199A HUP0301199A HUP0301199A2 HU P0301199 A2 HUP0301199 A2 HU P0301199A2 HU 0301199 A HU0301199 A HU 0301199A HU P0301199 A HUP0301199 A HU P0301199A HU P0301199 A2 HUP0301199 A2 HU P0301199A2
Authority
HU
Hungary
Prior art keywords
active pharmaceutical
pharmaceutical ingredient
dioxo
thiazolidinedione
antidiabetic
Prior art date
Application number
HU0301199A
Other languages
English (en)
Inventor
Michael Millan
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9900427&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0301199(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of HUP0301199A2 publication Critical patent/HUP0301199A2/hu
Publication of HUP0301199A3 publication Critical patent/HUP0301199A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A találmány az 5-[4-{2-[N-metil-.N-(2-piridil)-amino]-etoxi}-benzil]-2,4-dioxo-tiazolidin-kálium-sóra és szolvátjaira mint újgyógyszerhatóanyagra, a gyógyszerhatóanyag előállítási eljárására, agyógyszerhatóanyagot tartalmazó gyógyszerkészítményekre, valamint agyógyszerhatóanyag gyógyászati alkalmazására vonatkozik. Ó
HU0301199A 2000-09-29 2001-09-28 A dioxo-thiazolidinedione and its use as antidiabetic HUP0301199A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0023970.7A GB0023970D0 (en) 2000-09-29 2000-09-29 Novel pharmaceutical
PCT/GB2001/004346 WO2002026736A1 (en) 2000-09-29 2001-09-28 A thiazolidinedione derivative and its use as antidiabetic

Publications (2)

Publication Number Publication Date
HUP0301199A2 true HUP0301199A2 (hu) 2003-11-28
HUP0301199A3 HUP0301199A3 (en) 2005-04-28

Family

ID=9900427

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0301199A HUP0301199A3 (en) 2000-09-29 2001-09-28 A dioxo-thiazolidinedione and its use as antidiabetic

Country Status (34)

Country Link
US (1) US20040038968A1 (hu)
EP (2) EP1795531A1 (hu)
JP (1) JP2004509960A (hu)
KR (2) KR100822135B1 (hu)
CN (2) CN1620453B (hu)
AP (1) AP1841A (hu)
AT (1) ATE368038T1 (hu)
AU (2) AU2001292034B2 (hu)
BG (1) BG107678A (hu)
BR (1) BR0114364A (hu)
CA (1) CA2423978A1 (hu)
CY (1) CY1107767T1 (hu)
CZ (1) CZ2003849A3 (hu)
DE (1) DE60129576T2 (hu)
DK (1) DK1325000T3 (hu)
DZ (1) DZ3481A1 (hu)
EA (1) EA005110B1 (hu)
EC (1) ECSP034529A (hu)
ES (1) ES2290169T3 (hu)
GB (1) GB0023970D0 (hu)
HK (1) HK1058192A1 (hu)
HU (1) HUP0301199A3 (hu)
IL (2) IL155140A0 (hu)
MA (1) MA25913A1 (hu)
MX (1) MXPA03002867A (hu)
NO (2) NO324970B1 (hu)
NZ (1) NZ524932A (hu)
OA (1) OA12400A (hu)
PL (1) PL361157A1 (hu)
PT (1) PT1325000E (hu)
SK (1) SK3792003A3 (hu)
UA (1) UA76121C2 (hu)
WO (1) WO2002026736A1 (hu)
ZA (1) ZA200302438B (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU225919B1 (en) * 1999-12-18 2007-12-28 Richter Gedeon Nyrt Thiazolidine-derivatives, process for their preparation pharmaceutical and intermediates
HUP0800755A2 (en) 2008-12-11 2010-09-28 Richter Gedeon Nyrt Crystalline forms of rosiglitazone

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5646169A (en) * 1987-09-04 1997-07-08 Beecham Group P.L.C. Compounds for treating eating disorders in which blood glucose levels are raised
ATE186724T1 (de) * 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
GB9124513D0 (en) * 1991-11-19 1992-01-08 Smithkline Beecham Plc Novel process
GB9308487D0 (en) * 1993-04-23 1993-06-09 Smithkline Beecham Plc Novel compounds
GB9712866D0 (en) * 1997-06-18 1997-08-20 Smithkline Beecham Plc Novel method of treatment
GB9723295D0 (en) * 1997-11-04 1998-01-07 Smithkline Beecham Plc Novel process
CN1183130C (zh) * 1999-09-24 2005-01-05 中国人民解放军军事医学科学院毒物药物研究所 噻唑烷类衍生物及其医药用途
HU225919B1 (en) * 1999-12-18 2007-12-28 Richter Gedeon Nyrt Thiazolidine-derivatives, process for their preparation pharmaceutical and intermediates

Also Published As

Publication number Publication date
IL155140A0 (en) 2003-10-31
CY1107767T1 (el) 2013-04-18
CN1620453A (zh) 2005-05-25
AP2003002766A0 (en) 2003-03-31
DZ3481A1 (fr) 2002-04-04
MXPA03002867A (es) 2004-12-06
SK3792003A3 (en) 2004-04-06
NO20075507L (no) 2003-05-27
EP1795531A1 (en) 2007-06-13
KR100822135B1 (ko) 2008-04-15
MA25913A1 (fr) 2003-10-01
AU2001292034B2 (en) 2005-04-21
PT1325000E (pt) 2007-10-25
DE60129576T2 (de) 2008-04-17
CZ2003849A3 (cs) 2004-03-17
NO324970B1 (no) 2008-01-14
HUP0301199A3 (en) 2005-04-28
ATE368038T1 (de) 2007-08-15
ECSP034529A (es) 2003-05-26
KR20070089258A (ko) 2007-08-30
IL155140A (en) 2010-06-30
AP1841A (en) 2008-04-30
OA12400A (en) 2004-09-06
EA200300423A1 (ru) 2003-08-28
CN1620453B (zh) 2010-12-08
CN101961333A (zh) 2011-02-02
EP1325000B1 (en) 2007-07-25
AU9203401A (en) 2002-04-08
JP2004509960A (ja) 2004-04-02
PL361157A1 (en) 2004-09-20
NO20031434L (no) 2003-05-27
DK1325000T3 (da) 2007-11-12
BR0114364A (pt) 2003-12-09
NZ524932A (en) 2005-06-24
WO2002026736A1 (en) 2002-04-04
EA005110B1 (ru) 2004-10-28
HK1058192A1 (en) 2004-05-07
NO20031434D0 (no) 2003-03-28
ES2290169T3 (es) 2008-02-16
EP1325000A1 (en) 2003-07-09
KR20030032058A (ko) 2003-04-23
UA76121C2 (en) 2006-07-17
US20040038968A1 (en) 2004-02-26
DE60129576D1 (de) 2007-09-06
GB0023970D0 (en) 2000-11-15
BG107678A (bg) 2003-11-28
CA2423978A1 (en) 2002-04-04
ZA200302438B (en) 2004-04-28

Similar Documents

Publication Publication Date Title
HUP0204122A2 (hu) Dioxo-tiazolidint és hetformint tartalmazó gyógyszerkészítmény és felhasználása
TR200103337T2 (tr) Protez inhibit”rleri olarak yeni bileçikler ve bileçimler
SE0102438D0 (sv) New compounds
GEP20063890B (en) Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
HUP0104303A2 (hu) Gyógyszerkészítmény egy inzulin szenzibilizátor és egy másik antidiabetikus szer módosított hatóanyag-felszabadítására
SE0001899D0 (sv) New compounds
EE05383B1 (et) Polarlkarboksamiidhendid,ÁnendeÁvalmistamineÁjaÁkasutamineÁlipiiditasetÁalandavateÁtoimeainetenaÁningÁneidÁsisaldavÁfarmatseutilineÁkompositsioon
HUP0302131A2 (hu) Gyógyászati tramadolsók, ezeket tartalmazó gyógyszerkészítmények
HUP0303082A2 (hu) Szubsztituált indolil-oxo-acetil-piperazinszármazékok, ezeket tartalmazó készítmények és vírusellenes alkalmazásuk
DE60220055D1 (de) 4-(4-methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2-yl)harnstoff und dessen verwendung bei der behandlung von mit glycogensynthasekinase-3 (gsk3) assoziierten leiden
ATE66605T1 (de) Waessrige arzneiformulierungen des piroxicammonohydrats.
IS5851A (is) Ný lyf til inntöku 5-HT4 gerandefna eða mótlyfja
HUP0300972A2 (hu) Gatifloxacin-pentahidrát
DE60135261D1 (de) Arzneimittel, welches ein Peptid kleiner oder mittlerer Grösse enthält
NO20040702L (no) Kombinerte preparater som inneholder 1,4-benzotiepin-1,1-dioksidderivater og andre aktive substanser og anvendelsen derav
HUP0300777A2 (hu) Tiazolidindion-származék tartarátsója
HUP0300863A2 (hu) N-(3,5-diklór-2-metoxi-fenil)-4-metoxi-3-(1-piperazinil)-benzolszulfonamid, eljárás elżállítására és a vegyületet tartalmazó gyógyszerkészítmény
HUP0301199A2 (hu) Dioxo-tiazolidin-származék és antidiabetikumként történő alkalmazása
HUP0300938A2 (hu) Az 5-[4-{2-[N-metil-N-(2-piridil)-amino]-etoxi}-benzil]-2,4-dioxo-tiazolidin hidrokloridsója
HUP0300778A2 (hu) Tiazolidindion-származék tartarátsója
HUP0400776A2 (hu) N-(Metiletilaminokarbonil)-4-(3-metilfenilamino)-3-piridilszulfonamid és gyűrűs oligoszacharidok kompozíciói, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
HUP0300770A2 (hu) Tiazolidindion-származék tartarátsója
HUP0301137A2 (hu) Dioxo-tiazolidin-só diabetes mellitus kezelésére, eljárás az előállítására és ezt tartalmazó gyógyszerkészítmény
HUP0302135A2 (hu) A toraszemid új V. polimorf módosulata, eljárás előállítására, alkalmazása nyersanyagként, valamint ilyen módosulatot tartalmazó gyógyászati készítmények
HUP0300724A2 (hu) Tiazolidindion-származék tartarátsója

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees